• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Grand Challenges in Allergen Immunotherapy.变应原免疫疗法的重大挑战。
Front Allergy. 2021 Aug 5;2:710345. doi: 10.3389/falgy.2021.710345. eCollection 2021.
2
Allergen immunotherapy: routes, safety, efficacy, and mode of action.变应原免疫疗法：途径、安全性、疗效及作用方式。
Immunotargets Ther. 2013 Jul 22;2:61-71. doi: 10.2147/ITT.S31467. eCollection 2013.
3
Allergen Immunotherapy: The Evidence Supporting the Efficacy and Safety of Subcutaneous Immunotherapy and Sublingual Forms of Immunotherapy for Allergic Rhinitis/Conjunctivitis and Asthma.变应原免疫治疗：皮下免疫治疗和舌下免疫治疗变应性鼻炎/结膜炎和哮喘的疗效和安全性的证据。
J Allergy Clin Immunol Pract. 2024 Jun;12(6):1415-1427. doi: 10.1016/j.jaip.2024.04.034. Epub 2024 Apr 27.
4
Efficacy and Safety of Subcutaneous and Sublingual Immunotherapy for Allergic Rhinoconjunctivitis and Asthma.皮下和舌下免疫疗法治疗变应性鼻结膜炎和哮喘的疗效与安全性
Otolaryngol Clin North Am. 2017 Dec;50(6):1111-1119. doi: 10.1016/j.otc.2017.08.011. Epub 2017 Sep 28.
5
Allergen immunotherapy for long-term tolerance and prevention.变应原免疫疗法促进长期耐受与预防。
J Allergy Clin Immunol. 2022 Mar;149(3):802-811. doi: 10.1016/j.jaci.2022.01.007. Epub 2022 Jan 24.
6
Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma.实验变应原免疫治疗方法：过敏性哮喘小鼠模型中的皮下和舌下脱敏。
Methods Mol Biol. 2021;2223:295-335. doi: 10.1007/978-1-0716-1001-5_20.
7
8
Does evidence support the use of cat allergen immunotherapy?有证据支持使用猫过敏原免疫疗法吗？
Curr Opin Allergy Clin Immunol. 2018 Aug;18(4):350-355. doi: 10.1097/ACI.0000000000000457.
9
Future directions in allergen immunotherapy.变应原免疫治疗的未来方向。
Allergy Asthma Proc. 2022 Jul 1;43(4):356-362. doi: 10.2500/aap.2022.43.210098.
10
Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma.变应性哮喘小鼠模型中的皮下和舌下免疫疗法。
Methods Mol Biol. 2017;1559:137-168. doi: 10.1007/978-1-4939-6786-5_11.

引用本文的文献

1
Role of microRNAs in type 2 diseases and allergen-specific immunotherapy.微小RNA在2型疾病及变应原特异性免疫治疗中的作用
Front Allergy. 2022 Sep 12;3:993937. doi: 10.3389/falgy.2022.993937. eCollection 2022.

本文引用的文献

1
Molecular Diagnosis in House Dust Mite-Allergic Patients Suggests That Der p 23 Is Clinically Relevant in Asthmatic Children.屋尘螨过敏患者的分子诊断表明 Der p 23 在哮喘儿童中具有临床相关性。
J Investig Allergol Clin Immunol. 2020 Apr 24;30(2):127-132. doi: 10.18176/jiaci.0431. Epub 2019 Jul 8.
2
Intralymphatic Immunotherapy: Update and Unmet Needs.淋巴内免疫疗法：最新进展与未满足的需求
Int Arch Allergy Immunol. 2019;178(2):141-149. doi: 10.1159/000493647. Epub 2018 Nov 2.
3
The Use of Biomarkers to Predict Aero-Allergen and Food Immunotherapy Responses.利用生物标志物预测空气变应原和食物免疫治疗反应。
Clin Rev Allergy Immunol. 2018 Oct;55(2):190-204. doi: 10.1007/s12016-018-8678-z.
4
Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial.舌下草花粉免疫疗法治疗2年对中重度季节性过敏性鼻炎患者3年时鼻过敏原激发反应的影响：GRASS随机临床试验
JAMA. 2017 Feb 14;317(6):615-625. doi: 10.1001/jama.2016.21040.
5
Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper.用于监测变应性鼻炎和变应性哮喘变应原免疫治疗临床疗效的生物标志物：EAACI 立场文件。
Allergy. 2017 Aug;72(8):1156-1173. doi: 10.1111/all.13138. Epub 2017 Apr 6.
6
The effect of component-resolved diagnosis on specific immunotherapy prescription in children with hay fever.变应性鼻炎患儿特异性免疫治疗中成分诊断的作用。
J Allergy Clin Immunol. 2014 Jul;134(1):75-81. doi: 10.1016/j.jaci.2014.01.042. Epub 2014 May 1.
7
Conversion of Der p 23, a new major house dust mite allergen, into a hypoallergenic vaccine.将 Der p 23（一种新型主要屋尘螨过敏原）转化为低变应原疫苗。
J Immunol. 2014 May 15;192(10):4867-75. doi: 10.4049/jimmunol.1400064. Epub 2014 Apr 14.
8
Allergy immunotherapy adherence and delivery route: location does not matter.变应性免疫疗法的依从性与给药途径：地点无关紧要。
J Allergy Clin Immunol Pract. 2014 Mar-Apr;2(2):156-60. doi: 10.1016/j.jaip.2014.01.010.
9
The special challenge of nonadherence with sublingual immunotherapy.舌下免疫治疗的特殊挑战。
J Allergy Clin Immunol Pract. 2014 Mar-Apr;2(2):152-5. doi: 10.1016/j.jaip.2014.01.003.
10
Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens.变应原特异性免疫治疗的机制：过敏原免疫耐受中的多种抑制性因子。
J Allergy Clin Immunol. 2014 Mar;133(3):621-31. doi: 10.1016/j.jaci.2013.12.1088.

Grand Challenges in Allergen Immunotherapy.

作者信息

Cox Linda

机构信息

Retired, Casper, WY, United States.

出版信息

Front Allergy. 2021 Aug 5;2:710345. doi: 10.3389/falgy.2021.710345. eCollection 2021.

DOI:10.3389/falgy.2021.710345
PMID:35387004
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8974864/
Abstract
摘要